Skip to main content
Log in

Low Daily Dose of Antioxidant Probucol Decreases Incidence and Severity of Restenosis after Transluminal Coronary Balloon Angioplasty

  • Biophysics and Biochemistry
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Antioxidant probucol in both high (1000 mg) and low (250 mg) daily doses effectively reduced manifestations of oxidative stress in patients with atherosclerosis (assessed by in vivo accumulation of lipoperoxides in atherogenic LDL). When probucol was administered in a dose of 250 mg/day for 7–10 days before transluminal balloon coronary angioplasty and then for 6 months after surgery, the incidence of restenosis decreased to 25% compared to 45% in the control (without probucol therapy). In the group of operated patients receiving probucol (250 mg/day for 6 months) the minimal artery lumen was significantly higher, and the degree of artery occlusion significantly lower than in the control group not treated with probucol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Yu. N. Belenkov, T. A. Batyraliev, I. V. Pershukov, and A. N. Samko, Kardiologiya, 11, No.9, 68–72 (2002).

    Google Scholar 

  2. N. K. Zenkov, N. V. Kandalintseva, V. Z. Lankin, et al., Phenol Bioantioxidants [in Russian], Novosibirsk (2003).

  3. N. K. Zenkov, V. Z. Lankin, and E. B. Men’shchikova, Oxidative Stress: Biochemical and Pathophysiological Aspects [in Russian], Moscow (2001).

  4. V. Z. Lankin, A. K. Tikhaze, and Yu. N. Belenkov, Kardiologiya, 40, No.7, 48–61 (2000).

    Google Scholar 

  5. A. K. Tikhaze, V. Z. Lankin, G. G. Konovalova, et al., Byull. Eksp. Biol. Med., 128, No.8, 186–189 (1999).

    Google Scholar 

  6. B. G. Brown, E. Bolson, M. Frimer, et al., Circulation, 55, 329–337 (1977).

    CAS  PubMed  Google Scholar 

  7. D. L. Fischman, M. B. Leon, D. S. Baim, et al., N. Engl. J. Med., 331, 496–501 (1994).

    CAS  PubMed  Google Scholar 

  8. G. Hansson, C. Malmsten, and O. Radmark, in: Prostaglandins and Related Substances, Amsterdam, New York, Oxford (1983), pp. 127–169.

  9. C. Landau, R. A. Lange, and L. D. Hillis, N. Engl. J. Med., 330, 981–993 (2003).

    Google Scholar 

  10. A. C. Newby, Toxicol. Lett., 112–113, 519–529 (2000).

    PubMed  Google Scholar 

  11. J. Nourooz-Zadeh, J. Tajaddini-Sarmadi, and S. P. Wolff, Anal. Biochem., 220, 403–409 (1994).

    CAS  PubMed  Google Scholar 

  12. J. Rodest, G. Cote, J. Lesperanse, et al., N. Engl. J. Med., 337, 365–372 (1997).

    PubMed  Google Scholar 

  13. K. Tanaka, K. Hayashi, T. Shingu, et al., Cardiovasc. Drugs Ther., 12, 19–28 (1998).

    CAS  PubMed  Google Scholar 

  14. J. C. Tardif, G. Cote, J. Lesperanse, et al., Circulation, 97, 429–436 (1998).

    PubMed  Google Scholar 

  15. H. Yokoi, H. Daida, Y. Kuwabara, et al., J. Am. Coll. Cardiol., 30, 855–862 (1997).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. I. Kaminnyi.

Additional information

__________

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 139, No. 2, pp. 150–152, February, 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaminnyi, A.I., Lankin, V.Z., Samko, A.N. et al. Low Daily Dose of Antioxidant Probucol Decreases Incidence and Severity of Restenosis after Transluminal Coronary Balloon Angioplasty. Bull Exp Biol Med 139, 183–185 (2005). https://doi.org/10.1007/s10517-005-0242-1

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-005-0242-1

Key Words

Navigation